BBCNEWS Click - Short Edition June 4, 2024 03:43:00
But this is a possible game changer. katerina says her solution is almost foolproof. this trial is first of its kind. we're building the software, so it's a software product, but it's considered to be a medical device. so it's treated as if we were developing implants, manufacturing implants. so, it has to be the same level of scrutiny and certification. but, with all new tech, there's room for improvement. it needs more stents on the shelf. people don't have to have one stent, like, today i used one, but using presize i could have used four or five different types. you know what? that was pre...